my country’s myo-inositol market is gradually expanding and the industry concentration is high

Myo-inositol, also known as myositol, fiberitol, cyclohexanol, etc., refers to a cyclic sugar alcohol with high content in vegetables, grains and fruits, and can participate in related material metabolism activities in animal and plant cells. Inositol has a variety of functions. It can lower cholesterol to a certain extent, promote hair growth, and can also help redistribute body fat. With the continuous advancement of science and technology, the artificial synthesis technology of myo-inositol continues to advance, and its application fields are gradually broadened, and it is mostly used in food and beverage, fertilizer processing, cosmetics, medicine and other fields.

From the downstream of my country’s inositol industry chain, medicine and cosmetics have become the largest application market for inositol, accounting for 42.47% of the overall market; followed by food and beverage, accounting for 30.41%; ranking third is Feed processing, market share is 27.12%.

In recent years, the income level of my country’s residents has continued to grow, consumption levels have gradually upgraded, health management awareness has gradually improved, and consumer health care expenditures have gradually increased. According to data released by the National Bureau of Statistics, in 2022, the per capita health care expenditure of Chinese residents will be 2,120 yuan, an increase of 0.2% over the previous year. And as the aging of my country’s population gradually deepens, the number of elderly people gradually increases, and the number of patients with basic diseases, chronic diseases and other diseases gradually increases, and the demand for medicines continues to grow. Against this background, the scale of my country’s pharmaceutical market has shown a trend of increasing year by year. In 2022, the size of my country’s pharmaceutical market will reach 1,654.24 billion yuan. As a basic material for medicine, the market of myo-inositol is gradually growing.

According to the “China’s Inositol Industry Market Monitoring and Future Development Prospects Research Report 2023-2027” released by the Industrial Research Center, At this stage, my country’s research on myo-inositol is gradually deepening, the industrial structure of myo-inositol is gradually upgrading, and the product types are gradually enriched. Inositol deep-processed products such as aminocyclic sugar alcohols, inositol organic acid esters, inositol peptides, and phosphoinositide esters are gradually becoming more and more popular. Increase, promote the continuous development of myo-inositol market. In addition, myo-inositol is also widely used in the field of food and beverages, such as the introduction of vitamin functional drinks with myo-inositol as the main ingredient, weight loss and lipid-lowering foods containing myo-inositol, etc. With the rapid development of my country’s downstream market, the demand for myo-inositol continues to grow, promoting the gradual expansion of its market size. From 2017 to 2022, my country’s inositol market size will grow from 931.38 billion yuan to 1.25788 billion yuan, with an average annual compound growth rate of 6.19%.

Industry analysts said that at present, my country’s inositol market is highly concentrated, and leading companies have emerged. The major inositol companies in my country include Yuwei Biotech, Fuli Biotech, Haotian Pharmaceutical, Chen’s Biotech, Xinhe Biochemical, Hongtao Biotech, Tiancheng Yili, etc. Among them, Haotian Pharmaceutical has the largest market share, accounting for 32.47%; followed by Yuwei Biotechnology, with a market share of 20.31%; and thirdly ranked Chen’s Biotechnology, with a market share of 13.59%. It can be seen from this that Haotian Pharmaceutical and Yuwei Biotechnology have become leading companies in my country’s inositol industry.